Larvol Delta - AGB101-PDP-Clinical-Trial-Evaluating-the-Efficacy-and-Safety-of-AGB101-for-Treatment-of-Parkinson39s-Disease-Related-Psychosis

levetiracetam low dose (AGB101) - AgeneBio

http://clinicaltrials.gov/ct2/show/NCT05824728

Sep 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next